XML 50 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities:    
Net income $ 98,336 $ 88,048
Adjustments to reconcile net income to net cash provided by operating activities:    
Net realized and unrealized (loss) gain on derivatives and foreign exchange 8,852 (9,149)
Net loss on restructuring and extinguishment of debt 20,269 445
Write-off of debt issuance costs 4,080 386
Lower of cost or estimated fair value adjustment on corporate loans held for sale 4,749 (10,401)
Provision for loan losses 11,068 46,498
Impairment charges 5,862 733
Share-based compensation 980 614
Net unrealized gain on residential mortgage-backed securities, carried at estimated fair value (6,444) (3,047)
Net realized and unrealized gain on investments (98,894) (53,920)
Depreciation and net amortization (5,232) (16,146)
Changes in assets and liabilities:    
Interest receivable 1,921 6,583
Other assets (12,881) (8,444)
Related party payable 10,708 5,749
Accounts payable, accrued expenses and other liabilities 84 1,103
Net cash provided by operating activities 39,678 44,716
Cash flows from investing activities:    
Principal payments from corporate loans 500,167 621,928
Principal payments from securities available-for-sale and other securities, at estimated fair value 54,819 18,791
Principal payments from residential mortgage-backed securities, at estimated fair value 2,523 1,552
Proceeds from sales of corporate loans 100,807 167,981
Proceeds from sales of securities available-for-sale and other securities, at estimated fair value 11,977 93,641
Proceeds from equity investments 2,007 3,216
Purchases of corporate loans (434,408) (291,143)
Purchases of securities available-for-sale and other securities, at estimated fair value (20,990) (13,085)
Purchases of equity and other investments (32,345) (89,946)
Net change in proceeds, purchases, and settlements of derivatives (2,019) (6,243)
Net change in restricted cash and cash equivalents 174,292 (424,330)
Net cash provided by investing activities 356,830 82,362
Cash flows from financing activities:    
Issuance of collateralized loan obligation secured notes 0 31,876
Retirement of collateralized loan obligation secured notes (167,633) (93,888)
Proceeds from credit facilities 0 28,500
Repayment of credit facilities (61,700)  
Repayment of convertible senior notes 0 (23,495)
Proceeds from senior notes 0 111,418
Net proceeds from issuance of preferred stock 361,622  
Distributions on common shares (53,243) (46,384)
Repurchase and cancellation of common shares 0 (96)
Other capitalized costs 0 (317)
Net cash provided by financing activities 79,046 7,614
Net increase in cash and cash equivalents 475,554 134,692
Cash and cash equivalents at beginning of period 237,606 392,154
Cash and cash equivalents at end of period 713,160 526,846
Supplemental cash flow information:    
Cash paid for interest 43,494 49,640
Net cash paid for income taxes 4,462 45
Non-cash investing and financing activities:    
Issuance of restricted common shares 3,282 2,446
Loans transferred from held for investment to held for sale 21,388 46,077
Loans transferred from held for sale to held for investment 0 7,504
Preferred share distributions declared, not yet paid 6,738  
Conversion of convertible senior notes to common shares 186,254  
Affiliates
   
Changes in assets and liabilities:    
Accrued interest payable (1,055) 541
Nonaffiliates
   
Changes in assets and liabilities:    
Accrued interest payable $ (2,725) $ (4,877)